http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2519228-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2b2682593711320846694fd69b84b578
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7068
filingDate 2013-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f920b02e0af14dbd3fba8ab677938c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ddfdc4bc4acbbd32ad616de2d4a247d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e90d0dc1d2c649378b2417885b4af44f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53752c2bd3e3f3c747fc33594ac1156b
publicationDate 2014-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2519228-C1
titleOfInvention Method for prevention of cerebral ischemia in precerebral vasculoplasty
abstract FIELD: medicine. n SUBSTANCE: preparation citicoline is administered for the purpose of preventing cerebral ischemia in precerebral vasculoplasty prior to and after a carotid occlusion. Prior to the occlusion, citicoline is administered in a dose of 2000 mg in 0.9% sodium chloride 400 ml for a period of time sufficient for approaching the operated vessels, and terminated 5-7 minutes prior to the occlusion. After the occlusion, citicoline is administered starting from the second postoperative day for 5-8 days daily once a day, in a dose of 1000 mg in 0.9% sodium chloride 200 ml. n EFFECT: more effective prevention of cerebral ischemia in precerebral vasculoplasty by the empirically selected regimen of the staged administration of citicoline. n 4 ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2611357-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2578451-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2759654-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2734466-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2567275-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2639816-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2648178-C1
priorityDate 2013-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006342184-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2008134143-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2255741-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NZ-337305-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID4684
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427059
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13804
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23663870
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419589196
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447722571
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4497
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535113
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23663641
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450935972
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID4684

Total number of triples: 40.